Guardian Pharmacy Financials
| GRDN Stock | 24.94 0.02 0.08% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 42.9 M | 40.9 M |
|
|
The financial analysis of Guardian Pharmacy is a critical element in measuring its lifeblood. Investors should not minimize Guardian Pharmacy's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Guardian | Select Account or Indicator |
Understanding current and past Guardian Pharmacy Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Guardian Pharmacy's financial statements are interrelated, with each one affecting the others. For example, an increase in Guardian Pharmacy's assets may result in an increase in income on the income statement.
Guardian Pharmacy Stock Summary
Guardian Pharmacy competes with Regional Health, CIMG, RDE,, and HomesToLife. Guardian Pharmacy is entity of United States. It is traded as Stock on NYSE exchange.Specialization | Healthcare, Medical Care Facilities |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| CUSIP | 40145W101 |
| Location | Georgia; U.S.A |
| Business Address | 300 Galleria Parkway |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Benchmark | Dow Jones Industrial |
| Website | guardianpharmacy.com |
| Phone | 404 810 0089 |
Guardian Pharmacy Key Financial Ratios
| Revenue | 1.05 B | ||||
| Net Income | 23.9 M | ||||
| Total Asset | 271.17 M |
Guardian Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guardian Pharmacy's current stock value. Our valuation model uses many indicators to compare Guardian Pharmacy value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guardian Pharmacy competition to find correlations between indicators driving Guardian Pharmacy's intrinsic value. More Info.Guardian Pharmacy Services, is rated below average in revenue category among its peers. It is rated below average in net income category among its peers making up about 0.02 of Net Income per Revenue. The ratio of Revenue to Net Income for Guardian Pharmacy Services, is roughly 43.77 . At this time, Guardian Pharmacy's Total Revenue is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guardian Pharmacy's earnings, one of the primary drivers of an investment's value.Guardian Pharmacy Systematic Risk
Guardian Pharmacy's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Guardian Pharmacy volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Guardian Pharmacy correlated with the market. If Beta is less than 0 Guardian Pharmacy generally moves in the opposite direction as compared to the market. If Guardian Pharmacy Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Guardian Pharmacy is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Guardian Pharmacy is generally in the same direction as the market. If Beta > 1 Guardian Pharmacy moves generally in the same direction as, but more than the movement of the benchmark.
Guardian Pharmacy December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Guardian Pharmacy help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Guardian Pharmacy Services,. We use our internally-developed statistical techniques to arrive at the intrinsic value of Guardian Pharmacy Services, based on widely used predictive technical indicators. In general, we focus on analyzing Guardian Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Guardian Pharmacy's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.17 | |||
| Information Ratio | 0.2413 | |||
| Maximum Drawdown | 21.67 | |||
| Value At Risk | (5.35) | |||
| Potential Upside | 6.15 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.